Related Experiment Video
Updated: Aug 16, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Altered agonist-activated 86Rb+ efflux from arteries in canine renal hypertension
1Bockus Research Institute, Graduate Hospital, Philadelphia, PA 19146.
Basal rubidium-86 efflux rate constants were lower in renal arteries of hypertensive dogs compared to controls. Norepinephrine increased efflux similarly in both groups, while serotonin had a lesser effect in hypertensive coronary arteries.
Area of Science:
- Cardiovascular Physiology
- Renal Hypertension
- Vascular Biology
Background:
- Renal hypertension is associated with altered vascular function.
- Understanding ion transport in hypertensive vasculature is crucial for therapeutic development.
Purpose of the Study:
- To investigate differences in basal and stimulated 86Rubidium efflux rate constants in renal and coronary arteries of renal hypertensive dogs compared to controls.
- To assess the impact of norepinephrine and serotonin on vascular smooth muscle ion transport in hypertension.
Main Methods:
- Utilized the 86Rubidium (86Rb+) efflux assay to measure ion transport.
- Compared basal and drug-stimulated efflux rate constants between normotensive and renal hypertensive canine arterial segments.
- Administered norepinephrine and serotonin to evaluate their effects on vascular smooth muscle response.
Main Results:
- Basal 86Rb+ efflux rate constants were significantly lower in renal arteries of hypertensive dogs versus controls.
- No significant differences in basal 86Rb+ efflux were observed in coronary arteries between groups.
- Norepinephrine induced parallel increases in efflux rate constants for both hypertensive and control renal arteries.
- Serotonin elicited smaller increases in efflux rate constants in hypertensive coronary arteries compared to controls.
Conclusions:
- Renal hypertension is associated with impaired basal ion transport in renal arteries.
- Vascular smooth muscle responsiveness to vasoactive agents like serotonin may be altered in hypertensive coronary arteries.
- These findings suggest potential targets for therapeutic intervention in renal hypertension-related vascular dysfunction.
Related Concept Videos
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Antihypertensive Drugs: Action of β1 Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

